Generation of a Bioengineered Substitute of the Human Sclero-Corneal Limbus Using a Novel Decellularization Method
Ávila-Fernández P., Sánchez-Porras D., Etayo-Escanilla M., González-Gallardo C., Alaminos M., Chato-Astrain J.
Laboratory Study on Burns, published in Pharmaceutics (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- Pharmaceutics (2025)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 41471055
- PMCID
- PMC12736053
- DOI
- 10.3390/pharmaceutics17121540
- Citations
- 1
Abstract (original English)
Background : Severe dysfunction of the human limbus associated with limbal stem cell deficiency is a therapeutic challenge, especially when a structural alteration of the limbal niche is associated. Methods: We have evaluated seven decellularization protocols applied to 20 human sclero-corneal limbus, based on the use of SDS (protocol P1), SDS + NaCl (P2), SDS + triton X-100 + SDC + enzymatic treatment (P3), SDS + triton X-100 + SDC + enzymatic treatment + trypsin (P4), sulfobetains + DNAse (P5), sulfobetains + SDC + DNAse (P6) and SDC + DNAse (P7). The decellularization efficiency of each protocol, biocompatibility and safety, as well as their capability to support cell attachment and differentiation, were evaluated. Results: Results showed that the use of protocols P1 to P4, based on strong ionic detergents such as SDS, was not efficient for decellularizing the human limbus. Conversely, protocols P5, P6 and P7 removed more than 95% of DNA while preserving 60-100% of the extracellular matrix components. These protocols were biocompatible, as macrophages cultured with decellularized scaffolds were viable and differentiated to the pro-regenerative M2 phenotype (CD163/CD86 ratio > 2) without inducing a significant increase in reactive oxygen species (ROS). Protocols P6 and P7 supported cell attachment, survival and differentiation of corneal epithelial cells and four types of mes
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
Platelet-rich plasma and ablative fractional carbon dioxide laser therapy for chronic scar management: a systematic review
Systematic Review with a reported sample of 420 on Burns, Scar, published in Lasers Med Sci (2026) — summary generated from the PubMed abstract.
- 2026
- n = 420
Lasers Med Sci - Level ASystematic ReviewEurope PMC
Mesenchymal Stem Cell-Derived Extracellular Vesicles and Plant-Derived Nanovesicles as Cell-Free Therapies for Thermal Burn Healing: A Systematic Review of Preclinical Evidence and Delivery Strategies
Systematic Review on Chronic Wound, Burns, Scar, Chronic Inflammation, published in Med Sci (Basel) (2026) — summary generated from the PubMed abstract.
- 2026
Med Sci (Basel) - Level ASystematic ReviewPubMed
Autologous Nanofat Indications in Wound Healing: A Systematic Review.
Systematic Review with a reported sample of 3 on Chronic Wound, Burns, Scar, published in Biomedicines (2026) — summary generated from the PubMed abstract.
- 2026
- n = 3
Biomedicines - Level AMeta-analysisEurope PMC
Systematic review and meta-analysis of the use of micrografting technology in humans
Meta-analysis with a reported sample of 24 on Chronic Wound, Burns, Hair Loss, published in J Int Med Res (2025) — summary generated from the PubMed abstract.
- 2025
- n = 24
J Int Med Res1 citations - Level ASystematic ReviewPubMed
Encapsulation of Adipose-Derived Stem Cells in Collagen-Based Hydrogel: Regenerative Therapy for Burn Wound Healing.
Systematic Review on Chronic Wound, Burns, Scar, published in Ann Plast Surg (2025) — summary generated from the PubMed abstract.
- 2025
Ann Plast Surg - Level AMeta-analysisEurope PMC
Synergistic effects of mesenchymal stem cells and their secretomes with scaffolds in burn wound healing: a systematic review and meta-analysis of preclinical studies
Meta-analysis on Chronic Wound, Burns, Scar, Chronic Inflammation, published in J Transl Med (2025) — summary generated from the PubMed abstract.
- 2025
J Transl Med11 citations